Pulse Biosciences intends to redeem its remaining common stock warrants issued in July 2024, with an exercise deadline of July 13, 2026 at $11.00 per share or redemption at $0.01 per warrant. The company has already raised $123.7 million from its rights offering and warrant redemptions, demonstrating successful capital deployment and warrant valuation above redemption thresholds.